Intrarosa (prasterone) is a prescription drug used to treat moderate to severe pain during sex due to menopause. Intrarosa’s cost may depend on factors such as whether you have health insurance and ...
WALTHAM, Mass., May 21, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (AMAG) today announced it has completed the sale of its rights to Intrarosa ® (prasterone) to Millicent Pharma Limited, a ...
AMAG Pharmaceuticals has big ambitions for its women’s health business, so it’s snapped up the rights to a new med, Intrarosa, to beef up that portfolio. And it’s bringing on 150 new reps to detail ...
SYDNEY--(BUSINESS WIRE)--Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has expanded its original agreement with Endoceutics to commercialise Intrarosa® ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The US Food and Drug Administration (FDA) has approved prasterone (Intrarosa, Endoceutics Inc) to treat women with moderate to severe pain during sexual intercourse (dyspareunia) associated with ...
The FDA has approved Intrarosa (prasterone; Endoceutics) for the treatment of women experiencing moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause. The Food and ...
Adding to its portfolio in an increasingly attractive therapeutic area and hoping to bring back patients after a landmark Women's Health Initiative (WHI) study on estrogen treatments, Amag ...
After forfeiting two board seats and undertaking a strategic review, AMAG Pharmaceuticals is saying goodbye to its CEO and two of its drugs. But with another med likely being pulled from the market, ...
Drug major Lupin on Tuesday said its subsidiary Lupin Pharma has partnered with Endoceutics, a women's health focused biotech company, to commercialise Intrarosa in Canada. Lupin Pharma Canada has ...
DUBAI, UAE/PRNewswire/A unique non-estrogen prescription therapy, Intrarosa(TM), has been approved by the US Food and Drug Administration (FDA) and by the European Medical Agency (EMA), for the ...